Valeant Just Cranked Up Its Offer For Allergan

Valeant Pharmaceuticals just increased the cash portion of its offer to buy out Allergan.

The company is now offering $58.30 in cash per share, up from a previous offer of $48.30.

It continues to offer 0.83 shares of Valeant for every share of Allergan.

More to come...